List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 36 studies with search of:   "Hyperphosphatemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Another Phosphate binder
2 Not yet recruiting Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Intervention: Drug: MCI-196
3 Recruiting A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo;   Drug: Another phosphate binder
4 Recruiting A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
5 Recruiting A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-Based P Binders in Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
6 Completed A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
Conditions: Hyperphosphatemia;   Chronic Kidney Disease
Interventions: Drug: ASP1585;   Drug: Placebo;   Drug: Sevelamer hydrochloride
7 Recruiting A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia;   Dyslipidemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
8 Terminated Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Hyperphosphatemia;   Renal Osteodystrophy
Intervention:
9 Completed Long-Term Treatment on Bay 77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
Conditions: Hyperphosphatemia;   Dialysis
Intervention: Drug: Lanthanum Carbonate (BAY77-1931)
10 Completed BAY 77-1931 Long-Term Extension From Phase II Study
Condition: Hyperphosphatemia
Intervention: Drug: BAY 77-1931
11 Not yet recruiting Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
Conditions: Haemodialyzed Patients;   Hyperphosphatemia
Intervention: Drug: Sevelamer versus Calcium acetate
12 Active, not recruiting The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
Condition: Hyperphosphatemia
Intervention: Drug: Niacinamide
13 Completed The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
Condition: Hyperphosphatemia
Interventions: Drug: Niacinamide;   Drug: Placebo
14 Active, not recruiting Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
Conditions: Kidney Diseases;   Renal Insufficiency
Intervention: Drug: ILY101
15 Recruiting Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
Condition: Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Interventions: Drug: SBR759;   Drug: Sevelamer HCl;   Drug: SBR759;   Drug: Sevelamer HCl
16 Recruiting Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
Condition: Hyperphosphatemia
Interventions: Drug: Calcium Acetate Oral Solution 667 mg per 5 mL;   Drug: Calcium Acetate 667 mg GelCaps;   Dietary Supplement: Calcium Citrate 950 mg Caplets
17 Active, not recruiting Long-Term Effect of Lanthanum Carbonate on Bone
Condition: Hyperphosphatemia
Intervention:
18 Recruiting Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Condition: Hyperphosphatemia
Intervention:
19 Recruiting Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
Conditions: Hyperphosphatemia;   Kidney Disease
Interventions: Drug: Lanthanum carbonate;   Drug: Lanthanum carbonate
20 Completed An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis
Conditions: Chronic Kidney Disease;   Hyperphosphatemia
Intervention: Drug: Sevelamer carbonate (Renvela®)

Previous Page Studies Shown (1-20) Next (21-36)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services